Table 3 |
|
| Survival analyses of prognostic factors in ENKTL | |
| Variable | p value |
| Gender | |
| Male versus Female | 0.0658 |
| Age (years) | |
| ≤40y versus >40y | 0.8679 |
| Ann Arbor Stage | |
| Stage I, II versus Stage III, IV | 0.4129 |
| LDH level | |
| High versus Normal | 0.7703 |
| B symptoms | |
| Positive versus Negative | 0.0180* |
| IPI | |
| L/LI versus HI/H | 0.5418 |
| Treatment | |
| Single therapy versus Combined therapy | 0.0082* |
| LMP1 expression | |
| Positive versus Negative | 0.0201* |
| LMP2A expression | |
| Positive versus Negative | 0.0487* |
LDH: lactate dehydrogenase; IPI: international prognostic index.
L: low risk; LI: low-intermiediate risk; HI: high-intermiediate risk.
* P < 0.05.
Mao et al. Diagnostic Pathology 2012 7:178 doi:10.1186/1746-1596-7-178
